zhouzhou
Lv31
378 积分
2024-01-20 加入
-
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial
5天前
已关闭
-
Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial
5天前
已完结
-
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial
5天前
已完结
-
High blood eosinophil count is associated with more frequent asthma attacks in asthma patients
9天前
已关闭
-
Biologic Therapies for Severe Asthma in School-Age Children
10天前
已完结
-
住院2型糖尿病患者规范化胰岛素强化治疗对血糖波动的影响
14天前
已完结
-
MANAGEMENT OF PROTEIN DEFICIENCY IN SURGICAL PATIENTS
15天前
已关闭
-
Nutrition in Peritoneal Dialysis
16天前
已完结
-
Genetically proxied glucokinase activation and risk of diabetic complications: Insights from phenome-wide and multi-omics mendelian randomization
18天前
已完结
-
无症状低血糖及血糖波动对糖尿病心脏自主神经病变的影响
18天前
已关闭